| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-09 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |